Xcout Intel
First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Subscribe to see First Tracks Biotherapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
First Tracks Biotherapeutics, Inc. at a glance
First Tracks Biotherapeutics, Inc. is a biotech company headquartered in San Diego, United States. It is publicly listed (TRAX) with a market capitalisation of $1.5B. Xcout tracks 22 named people at First Tracks Biotherapeutics, Inc., including Daniel R. Faga (CEO, President & Director).
First Tracks Biotherapeutics, Inc. leadership
- Daniel R. FagaCEO, President & Director
- Daniel FagaPresident & CEO
- Ajim A. TamboliChief Financial Officer
- Ajim TamboliChief Financial Officer
- Paul F. LizzulChief Medical Officer
- Ben StoneChief Business Officer
16 more named people on record for First Tracks Biotherapeutics, Inc., with roles, board committees and tenure — see the full roster →
Recent First Tracks Biotherapeutics, Inc. news
4 corporate events on record, with sources — see the full timeline →
Get First Tracks Biotherapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on First Tracks Biotherapeutics, Inc. in Xcout Intel
- 22 named people with titles, LinkedIn and board committees
- 4 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access